Bridgehead presents on Development of Value Based Pricing and Risk-sharing in the UK
The Bridgehead Market Access team will be in Brussels on April 23rd to 24th at the Pharmaceutical & Medical Device Risk-Sharing & Value-Based Pricing & Reimbursement Schemes, Congress. This congress provides an important forum for discussions on innovative pricing and reimbursement agreements and the (often) conflicting objectives of pharmaceutical and medical technology manufacturers, payers, health technology assessors (HTA).
Jim Furniss, Bridgehead’s Director of Global Market Access Strategies, will be presenting on “Development of value based pricing and risk-sharing in the UK.” Jim will also be involved in the Panel Discussion: “When and to what extent should companies share risks?”
Bridgehead also plans to have a stand at this congress so please come along and say hello.
